GOLGA1

Across TCGA pan-cancer cohorts, GOLGA1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated GOLGA1 data layer compared with 26 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher GOLGA1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated GOLGA1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and CCRCC show a favorable association.

UCEC, LUAD, and CCRCC are the cancer types where GOLGA1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Quartile	All	1.000	0.863	.016	6	view →
LUAD	DFS	Median	All	0.885	1.000	.009	3	view →
CCRCC	OS	Tertile	II,III,IV	0.938	0.638	.033	3	view →
HNSC	OS	Median	III,IV	0.922	0.814	.044	1	view →
GBM	DFS	Quartile	All	0.576	0.811	.044	1	view →
LSCC	OS	Median	All	0.806	1.000	.045	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

GOLGA1–UCEC (OS)

Open the UCEC breakdown →